Health ❯ Healthcare ❯ Regulatory Agencies

FDA

Drug Approval Process Recalls Vaccine Approval Process Leadership Changes Drug Warnings Drug Approval Drug Approval Processes Product Recalls Drug Recalls Drug Safety

10 ARTICLES

last mo.

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

Manufacturer Inventia pulled specific lots after tests showed the tablets failed dissolution standards, raising concern they may not deliver a full dose.

3 ARTICLES

last mo.

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

9 ARTICLES

3mo ago

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

8 ARTICLES

3mo ago

FDA Elevates Nationwide Cough-Drop Recall to Class II

5 ARTICLES

3mo ago

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

23 ARTICLES

3mo ago

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

4 ARTICLES

4mo ago

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

19 ARTICLES

4mo ago

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

4 ARTICLES

5mo ago

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

9 ARTICLES

6mo ago

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

11 ARTICLES

7mo ago

FDA Approves First Wegovy Pill for Chronic Weight Management

7 ARTICLES

7mo ago

MediNatura Recalls All ReBoost and ClearLife Nasal Sprays Over Contamination Risk

5 ARTICLES

7mo ago

FDA Names Tracy Beth Høeg Acting CDER Director as OTC Drugs Chief Is Reassigned

12 ARTICLES

8mo ago

Walgreens Recalls Saline Nasal Spray After FDA Flags Bacterial Contamination

FDA

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

FDA Approves First Generic Single‑Dose Flu Drug

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

FDA Launches Retrospective Safety Study of Mifepristone

Pharmacal Recalls One Lot of MG217 Eczema Cream Over Staph Contamination

Reports Say Trump Signs Off on Plan to Remove FDA Chief Marty Makary

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

FDA Elevates Nationwide Cough-Drop Recall to Class II

Never miss stories about

FDA

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

FDA Approves First Wegovy Pill for Chronic Weight Management

MediNatura Recalls All ReBoost and ClearLife Nasal Sprays Over Contamination Risk

FDA Names Tracy Beth Høeg Acting CDER Director as OTC Drugs Chief Is Reassigned

Walgreens Recalls Saline Nasal Spray After FDA Flags Bacterial Contamination

Never miss stories about

FDA